Induction of Fos-like immunoreactivity in the basal ganglia by ether anaesthesia: Effects of injections of muscimol in rostral versus caudal substantia nigra pars reticulata

Experimental Brain Research

Volumn 142, Issue 2, 2002, Pages 227-240

  Shehab, S ^a   Julyan, T ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Basal ganglia; c fos; Ether; Muscimol; Substantia nigra

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANESTHETIC AGENT; MUSCIMOL;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CELL COUNT; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; GLOBUS PALLIDUS; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROINJECTION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TONIC SEIZURE;

ANESTHETICS, INHALATION; ANIMALS; BASAL GANGLIA; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EPILEPSY; ETHER, ETHYL; FEMALE; GABA AGONISTS; HALOTHANE; IMMUNOHISTOCHEMISTRY; MALE; MUSCIMOL; NEURAL PATHWAYS; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0036139640     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00221-001-0907-6     Document Type: Article

References (59)

1. Topographical projections of the cerebral cortex to the subthalamic nucleus
2. The substantia nigra pars reticulata, seizures and Fos expression
3. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat
4. Bulk flow of interstitial fluid after intracranial injection of blue dextran 2000
5. Endogenous control of epilepsy: The nigral inhibitory system
6. Involvement of nigral glutamatergic inputs in the control of seizures in a genetic model of absence epilepsy in the rat
7. The role of basal ganglia in the control of generalized absence seizures
8. Evidence for the involvement of the pallidum in the modulation of seizures in a genetic model of absence epilepsy in the rat
9. The use of c-fos as a metabolic marker in neuronal pathway tracing
10. Induction of Fos in glia-like cells after focal brain injury but not during Wallerian degeneration
11. Induction of c-fos mRNA and protein in neurons and glia after traumatic brain injury: Pharmacological characterization
12. Differential forebrain c-fos mRNA induction by ether inhalation and novelty: Evidence for distinctive stress pathways
13. Behavioural effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats
14. Progression and generalisation of seizure discharge: Anatomical and neurochemical substrates
15. Anatomical and neurochemical substrates of clonic and tonic seizures
16. Substantia nigra-mediated anticonvulsant actions: Role of nigral output pathways
17. The basal ganglia
18. The neostriatal mosaic: Compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey
19. Basal expression of the inducible transcription factors c-Jun, JunB, JunD, c-Fos, FosB, and Krox-24 in the adult rat brain
20. Activation of c-fos in the brain
21. Microinjection of muscimol into entopeduncular nucleus suppresses pilocarpine but not maximal electroshock seizures in rats
22. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation
23. Substantia nigra: Site of anticonvulsant activity mediated by γ-amino butyric acid
24. Ether anaesthesia produces massive induction of c-fos immunoreactivity in the basal ganglia which is blocked by intranigral injection of muscimol
25. Efferent projections of the subthalamic nucleus in the rat: Light and electron microscopic analysis with the PHA-L method
26. Cortical inputs to the subthalamus: Intracellular analysis
27. Expression of c-fos protein in rat brain by electrical stimulation of the pontine parabrachial nucleus
28. Investigation of glial cells in semithin sections: I. Identification of glial cells in the brain of young rats
29. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations
30. Induction of c-fos expression in hypothalamic magnocellular neurones requires synaptic activation and not simply increased spike activity
31. Autoradiographic estimation of the extent of reversible inactivation produced by microinjection of lidocaine and muscimol in the rat
32. Differential immunochemical markers reveal the normal distribution of brain macrophages and microglia in the developing rat brain
33. Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and jun
34. Mapping patterns of c-fos expression in the central nervous system after seizure
35. Maturation and segregation of brain networks that modify seizures
36. NeuN, a neuronal specific nuclear protein in vertebrates
37. Functional anatomy of the basal ganglia. II. The place of the subthalamic nucleus and external pallidum in basal ganglia circuitry
38. Regulation of seizure threshold by excitatory amino acids in the striatum and entopeduncular nucleus of rats
39. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord
40. Thalamus
41. Cellular responses to experimental brain injury
42. Histochemical fluorescence after application of neurochemicals to caudate nucleus and septal area in vivo
43. Precerebellar nuclei and red nucleus
44. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats
45. Expression of c-fos protein in the brain: Metabolic mapping at the cellular level
46. Regional expression of Fos-like immunoreactivity following seizures induced by pentylenetetrazole and maximal electroshock
47. The dorsal midbrain anticonvulsant zone∼III: Effects of efferent pathway transections on suppression of electroshock seizures and defence-like reactions produced by local injections of bicuculline
48. Regional distribution of the anticonvulsant and behavioural effects of muscimol injected into the substantia nigra of rats
49. Regional distribution of the anticonvulsant and behavioural effects of bicuculline injected into the pontine reticular formation of rats
50. Neurones of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity
51. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method
52. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain
53. Nitrous oxide or halothane, or both, fail to suppress c-fos expression in rat spinal cord dorsal horn neurons after subcutaneous formalin
54. Electrically induced convulsions
55. The comparison of effects of various anaesthetics on expression of Fos protein in the rat brain
56. Mapping of the motor pathways in rats: c-fos induction by intracortical microstimulation of the motor cortex correlated with efferent connectivity of the site of cortical stimulation
57. Microinjections of muscimol into lateral superior colliculus disrupt orienting and oral movements in the formalin model of pain
58. Dopamine antagonists induce fos-like-immunoreactivity in the substantia nigra and entopeduncular nucleus of the rat
59. Cortex: Areal and laminar structure